Shock duration after resuscitation is associated with occurrence of post-cardiac arrest acute kidney injury

J Korean Med Sci. 2015 Jun;30(6):802-7. doi: 10.3346/jkms.2015.30.6.802. Epub 2015 May 13.

Abstract

This retrospective observational study investigated the clinical course and predisposing factors of acute kidney injury (AKI) developed after cardiac arrest and resuscitation. Eighty-two patients aged over 18 yr who survived more than 24 hr after cardiac arrest were divided into AKI and non-AKI groups according to the diagnostic criteria of the Kidney Disease/Improving Global Outcomes (KDIGO) Clinical Practice Guidelines for AKI. Among 82 patients resuscitated from cardiac arrest, AKI was developed in 66 (80.5%) patients (AKI group) leaving 16 (19.5%) patients in the non-AKI group. Nineteen (28.8%) patients of the AKI group had stage 3 AKI and 7 (10.6%) patients received renal replacement therapy during admission. The duration of shock developed within 24 hr after resuscitation was shorter in the non-AKI group than in the AKI group (OR 1.02, 95% CI 1.01-1.04, P < 0.05). On Multiple logistic regression analysis, the only predisposing factor of post-cardiac arrest AKI was the duration of shock. In conclusion, occurrence and severity of post-cardiac arrest AKI is associated with the duration of shock after resuscitation. Renal replacement therapy is required for patients with severe degree (stage 3) post-cardiac arrest AKI.

Keywords: Acute Kidney Injury; Cardiac Arrest; Heart Arrest; Post-cardiac Arrest Syndrome; Renal Failure; Renal Replacement Therapy; Resuscitation.

Publication types

  • Observational Study

MeSH terms

  • Acute Kidney Injury / mortality*
  • Acute Kidney Injury / therapy*
  • Aged
  • Female
  • Heart Arrest / mortality*
  • Heart Arrest / therapy*
  • Humans
  • Incidence
  • Male
  • Middle Aged
  • Renal Replacement Therapy / mortality
  • Republic of Korea / epidemiology
  • Resuscitation / mortality*
  • Retrospective Studies
  • Risk Factors
  • Severity of Illness Index
  • Shock / mortality*
  • Survival Rate
  • Treatment Outcome